Beyond Air’s (XAIR) “Buy” Rating Reiterated at D. Boral Capital

D. Boral Capital reiterated their buy rating on shares of Beyond Air (NASDAQ:XAIR) in a report released on Tuesday morning,Benzinga reports. They currently have a $10.00 target price on the stock.

A number of other equities analysts have also recently issued reports on the stock. Wall Street Zen raised shares of Beyond Air to a “sell” rating in a research note on Saturday, March 7th. Weiss Ratings restated a “sell (e)” rating on shares of Beyond Air in a research report on Monday, December 22nd. Finally, Rodman & Renshaw assumed coverage on Beyond Air in a research note on Tuesday, January 20th. They issued a “buy” rating for the company. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Beyond Air currently has a consensus rating of “Hold” and a consensus target price of $10.00.

Beyond Air Stock Up 0.9%

Shares of NASDAQ XAIR opened at $0.81 on Tuesday. Beyond Air has a 12-month low of $0.67 and a 12-month high of $6.44. The company has a quick ratio of 4.77, a current ratio of 5.12 and a debt-to-equity ratio of 2.65. The firm’s 50-day simple moving average is $1.15 and its 200 day simple moving average is $1.58. The company has a market cap of $8.53 million, a price-to-earnings ratio of -0.15 and a beta of 0.41.

Beyond Air (NASDAQ:XAIR) last posted its quarterly earnings data on Friday, February 13th. The company reported ($0.85) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.54) by ($0.31). The firm had revenue of $2.19 million for the quarter, compared to analyst estimates of $2.15 million. Beyond Air had a negative return on equity of 268.82% and a negative net margin of 447.75%. On average, research analysts expect that Beyond Air will post -0.79 earnings per share for the current fiscal year.

Institutional Trading of Beyond Air

Hedge funds and other institutional investors have recently modified their holdings of the stock. Alpine Global Management LLC acquired a new position in Beyond Air during the third quarter valued at approximately $25,000. Osaic Holdings Inc. raised its stake in shares of Beyond Air by 26.4% during the 2nd quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock worth $29,000 after purchasing an additional 34,000 shares in the last quarter. Virtu Financial LLC acquired a new stake in shares of Beyond Air in the 3rd quarter valued at approximately $48,000. Geode Capital Management LLC boosted its holdings in shares of Beyond Air by 57.5% in the 4th quarter. Geode Capital Management LLC now owns 67,678 shares of the company’s stock valued at $49,000 after buying an additional 24,695 shares during the last quarter. Finally, Alyeska Investment Group L.P. bought a new position in shares of Beyond Air in the third quarter valued at $1,753,000. Institutional investors and hedge funds own 31.50% of the company’s stock.

About Beyond Air

Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.

The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.